| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Oncology
1 company
Vieira Roberto Wandenkolk is a President, Oncology at CORT. Recent filings cover 0 purchases and 11 sales. Those positions are worth an estimated $460K at current prices.
Vieira Roberto Wandenkolk's largest disclosed position is in CORT as President, Oncology, worth about $460K. The recent filings there lean toward selling, a net 66,962 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | CORT Corcept Therapeutics Incorporated | President, Oncology | Sale+OE | 8,333 | $116.10 | $967,447.91 | -67.9% | |
| Sep 16, 2026 | CORT Corcept Therapeutics Incorporated | President, Oncology | Sell | 296 | $100.82 | $29,842.72 | -7.0% | |
| Sep 2, 2026 | CORT Corcept Therapeutics Incorporated | President, Oncology | Sale+OE | 58,333 | $110.76 | $6,460,765.71 | -93.2% |